Keytruda hits the mark in another late-stage cancer trial

Merck ’s top-selling Keytruda has proven effective in yet another phase 3 trial, this time with esophageal cancer.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news